These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 32661375)

  • 1. Immune-mediated approaches against COVID-19.
    Florindo HF; Kleiner R; Vaskovich-Koubi D; Acúrcio RC; Carreira B; Yeini E; Tiram G; Liubomirski Y; Satchi-Fainaro R
    Nat Nanotechnol; 2020 Aug; 15(8):630-645. PubMed ID: 32661375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
    Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in skin science enable the development of a COVID-19 vaccine.
    Falo LD
    J Am Acad Dermatol; 2020 Oct; 83(4):1226-1227. PubMed ID: 32485211
    [No Abstract]   [Full Text] [Related]  

  • 5. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of SARS-CoV-2 vaccine candidates.
    Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F
    Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.
    Gupta T; Gupta SK
    Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation vaccine platforms for COVID-19.
    van Riel D; de Wit E
    Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus reinfections: three questions scientists are asking.
    Ledford H
    Nature; 2020 Sep; 585(7824):168-169. PubMed ID: 32887957
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C
    Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 herd immunity: where are we?
    Fontanet A; Cauchemez S
    Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 18. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    Vignesh R; Shankar EM; Velu V; Thyagarajan SP
    Front Immunol; 2020; 11():586781. PubMed ID: 33101320
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccines targeting SARS-CoV-2 tested in humans.
    Edwards KM
    Nat Med; 2020 Sep; 26(9):1336-1338. PubMed ID: 32839620
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.